MAM
Probus Insurance partners with Star Sports India for T20 World Cup 2024
Mumbai: Probus, an Insurtech company, is thrilled to announce its partnership with Star Sports India for the T20 World Cup 2024. As one of the Action replay partners to the prestigious tournament, Probus is set to enhance its presence and reach in the Indian markets. Along with this, the collaboration will also enable Probus to establish a strong visibility in the MENA region, where the matches will be aired.
Speaking on the development, Probus MD Rakesh Goyal said, “We are thrilled to team up with Star Sports India for the T20 World Cup 2024. This collaboration aligns with our mission to connect with diverse audiences and enhance our brand’s visibility on a global scale. Cricket enjoys a massive following across all age groups, making it an ideal platform to engage with a wide audience. By partnering with Star Sports India, which offers broadcast in multiple regional languages, we aim to reach every corner of India and beyond, ensuring our message resonates with billions of cricket fans.”
Probus in the past has associated with several sports partnerships, namely the Pro Kabaddi League and the ICC Men’s Cricket World Cup 2023. This year, Probus plans to further leverage its partnership with Star Sports India through dynamic digital content, and interactive social media initiatives designed to captivate audiences. Additionally, Probus will utilize innovative branding opportunities in this period to ensure maximum visibility and engagement throughout the T20 World Cup 2024.
This collaboration is a strategic move to strengthen Probus’s brand presence and engage millions of potential customers, reinforcing its commitment to innovation and customer-centricity in the Insurtech sector.
Probus today is renowned for its robust technology platform, revolutionizing the Insurtech industry. With ambitious plans to expand its reach and establish 100 branches, and 500 salesforce locations by 2027-28, Probus is poised to revolutionize the insurance landscape in India.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
